Immediate Impact

48 standout
Sub-graph 1 of 21

Citing Papers

Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy
2025 Standout
Tailoring traditional Chinese medicine in cancer therapy
2025 Standout
2 intermediate papers

Works of Yuandeng Luo being referenced

p53 haploinsufficiency and increased mTOR signalling define a subset of aggressive hepatocellular carcinoma
2020
Triptolide enhances TRAIL sensitivity of pancreatic cancer cells by activating autophagy via downregulation of PUM1
2019

Author Peers

Author Last Decade Papers Cites
Yuandeng Luo 166 81 24 64 12 263
Atsutaka Masuda 135 88 25 82 19 260
Xiaochuang Feng 207 132 20 67 16 292
Haigang Geng 122 62 21 64 18 255
Daniel R. Radiloff 209 64 32 92 11 324
Mingdian Lu 191 100 20 43 15 256
Liran Zhou 209 70 14 99 10 318
Fahmida Rasha 115 66 17 80 15 318
Zefeng Xuan 203 82 20 66 18 283
Tiziana Monteverde 219 97 19 78 11 300
Qi Sun 187 69 24 34 18 278

All Works

Loading papers...

Rankless by CCL
2026